News Daily News New Appropriate Use Criteria for Peripheral Artery Interventions: A Multisociety Collaboration L.A. McKeown December 18, 2018
News Daily News Two Trials Halted in Wake of Study Linking Paclitaxel-Coated Devices to Deaths in PAD L.A. McKeown December 17, 2018
News Conference News WCC 2018 Rising CVD Threatens Middle East and North Africa Todd Neale December 13, 2018
News Conference News WCC 2018 CVD, Other Noncommunicable Diseases Hit Lower-Income Countries With Heavy Financial Burden Todd Neale December 06, 2018
News Daily News NOACs Significantly Curb Risk of VTE in Cancer Patients L.A. McKeown December 06, 2018
News Features Bruises and Bumps: How Cardiology Meetings Survived the End of Direct Industry Sponsorship in Europe Todd Neale November 30, 2018
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for November 2018 Shelley Wood November 30, 2018
News Daily News Female Cardiologists and Interventionalists Rare, Isolated in Australia and New Zealand Shelley Wood November 22, 2018
News Conference News AHA 2018 AHA Puts Focus on the Impact of Violence on Cardiovascular Health Todd Neale November 14, 2018
News Daily News SORT-OUT IX: Statistical Mix-up Turns Trial’s Primary Endpoint Around Michael O'Riordan November 06, 2018
News Opinion Fellow Talk A Look Back at TCT 2018: What I Took Away From the Meeting Yashasvi Chugh, MD October 23, 2018
News Features The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine Shelley Wood October 22, 2018
News Daily News Isolated SAVR Volumes Slide as TAVR Numbers Mount in the US Yael L. Maxwell October 19, 2018
News Features Survey Says: Interventional Cardiologists Still Divided Over Appropriate Use Criteria Caitlin E. Cox October 18, 2018
News Conference News TCT 2018 Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos Michael O'Riordan October 02, 2018
Presentation TCT 2018 Patient Perspectives on Sham-Controlled Trials Presenter: Kenneth J. Cavanaugh Jr, Roxana Mehran, Debbe McCall September 23, 2018
Presentation TCT 2018 FDA Perspectives on Sham-Controlled Trials Presenter: Kenneth J. Cavanaugh Jr, Roxana Mehran, Hiren Mistry September 23, 2018